Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q413879> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q413879 subject Q8353060.
- Q413879 subject Q8567712.
- Q413879 subject Q8825202.
- Q413879 abstract "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Golimumab has been approved in 2013 for use in adults with moderately to severely active ulcerative colitis.In the same year, Johnson & Johnson, the parent company of Centocor, also received an approval from European Medicines Agency (EMEA) for the use of golimumab as a treatment for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Golimumab is marketed by Merck & Co, Inc. in Europe, pending final arbitration between J&J and Merck.".
- Q413879 atcPrefix "L04".
- Q413879 atcSuffix "AB06".
- Q413879 casNumber "476181-74-5".
- Q413879 fdaUniiCode "91X1KLU43E".
- Q413879 wikiPageExternalLink article.php?article_id=7069.
- Q413879 wikiPageWikiLink Q1053653.
- Q413879 wikiPageWikiLink Q130146.
- Q413879 wikiPageWikiLink Q1436668.
- Q413879 wikiPageWikiLink Q1477.
- Q413879 wikiPageWikiLink Q1536078.
- Q413879 wikiPageWikiLink Q18032037.
- Q413879 wikiPageWikiLink Q187255.
- Q413879 wikiPageWikiLink Q2035485.
- Q413879 wikiPageWikiLink Q247489.
- Q413879 wikiPageWikiLink Q249619.
- Q413879 wikiPageWikiLink Q333718.
- Q413879 wikiPageWikiLink Q422232.
- Q413879 wikiPageWikiLink Q422248.
- Q413879 wikiPageWikiLink Q5.
- Q413879 wikiPageWikiLink Q511097.
- Q413879 wikiPageWikiLink Q52849.
- Q413879 wikiPageWikiLink Q8353060.
- Q413879 wikiPageWikiLink Q8567712.
- Q413879 wikiPageWikiLink Q8825202.
- Q413879 atcPrefix "L04".
- Q413879 atcSuffix "AB06".
- Q413879 casNumber "476181".
- Q413879 unii "91".
- Q413879 type ChemicalSubstance.
- Q413879 type Drug.
- Q413879 type ChemicalObject.
- Q413879 type Thing.
- Q413879 type Q8386.
- Q413879 comment "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.".
- Q413879 label "Golimumab".